Status:
UNKNOWN
The Burden of Lyme Disease (BOLD) in a Pandemic - Insights From an Online Cross-sectional and Prospective Cohort Survey
Lead Sponsor:
Dr. Daniel Cameron & Associates
Conditions:
COVID-19
Lyme Disease
Eligibility:
All Genders
12+ years
Brief Summary
A cross-sectional descriptive survey of the BOLD for individuals after having been ill with COVID-19 or have taken the COVID-19 vaccine will be compared with that of individuals who have neither been ...
Detailed Description
Primary research question: 1\. Will the BOLD be worse for individuals who have taken the COVID-19 vaccine? Secondary research questions: 1. Will the BOLD be worse for individuals who have been ill ...
Eligibility Criteria
Inclusion
- ≥12 years old
- a self-report of having been diagnosed with Lyme disease.
Exclusion
- There are no exclusion criteria.
Key Trial Info
Start Date :
July 7 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 7 2023
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT05312619
Start Date
July 7 2021
End Date
November 7 2023
Last Update
April 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Daniel Cameron
Mount Kisco, New York, United States, 10549